Sleep pill may ease depression symptoms in new trial
NCT ID NCT07555743
First seen May 08, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This study tests whether daridorexant, a sleep medication, can improve insomnia and depression in people with major depressive disorder. 134 adults will receive either the drug or a placebo for three months. Researchers will measure sleep quality and mood changes using questionnaires and overnight sleep tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitari de Bellvitge
Barcelona, Catalonia, 08908, Spain
Conditions
Explore the condition pages connected to this study.